Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004163
Status:
COMPLETED
Last Update Posted:
2017-04-18
First Post:
1999-12-10
Brief Title:
Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| salivary gland adenoid cystic carcinoma | View |
| stage III salivary gland cancer | View |
| stage IV salivary gland cancer | View |
| recurrent salivary gland cancer | View |
| salivary gland squamous cell carcinoma | View |
| salivary gland acinic cell tumor | View |
| low-grade salivary gland mucoepidermoid carcinoma | View |
| high-grade salivary gland mucoepidermoid carcinoma | View |
| salivary gland adenocarcinoma | View |
| salivary gland poorly differentiated carcinoma | View |
| salivary gland malignant mixed cell type tumor | View |